These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7983635)

  • 1. Evaluating biologic agents in rheumatoid arthritis: a framework for clinical trials.
    Strand V; Scott DL; Panayi GS
    J Rheumatol; 1994 Aug; 21(8):1390-2. PubMed ID: 7983635
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanding role of biologic agents in rheumatoid arthritis.
    Kalden JR
    J Rheumatol Suppl; 2002 Nov; 66():27-37. PubMed ID: 12435166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are there special considerations relevant to trials of biologic agents?
    Strand V
    J Rheumatol Suppl; 1994 Sep; 41():41-5; discussion 45-9. PubMed ID: 7799384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological agents in rheumatoid arthritis.
    Weinblatt ME
    J Rheumatol Suppl; 1992 Jan; 32():85-8; discussion 88-91. PubMed ID: 1613738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BiP: a new biologic immunomodulator for the treatment of rheumatoid arthritis.
    Panayi G; Corrigall V
    Autoimmun Rev; 2004 Jun; 3 Suppl 1():S16-7. PubMed ID: 15309771
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel biologic approaches to the treatment of rheumatoid arthritis.
    Sany J
    Rev Rhum Engl Ed; 1999 Nov; 66(11):548-59. PubMed ID: 10591116
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of biologicals in early rheumatoid arthritis.
    Haque UJ; Bathon JM
    Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):179-89. PubMed ID: 15588978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using short-term evidence to predict six-month outcomes in clinical trials of signs and symptoms in rheumatoid arthritis.
    Nixon RM; Bansback N; Stevens JW; Brennan A; Madan J
    Pharm Stat; 2009; 8(2):150-62. PubMed ID: 18942777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of rheumatoid arthritis with biologics.
    Panayi GS
    Schweiz Med Wochenschr Suppl; 1996; 80():22S-23S. PubMed ID: 8795120
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M
    J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances. A new era in treating arthritis.
    Emery P
    Health Serv J; 2009 Dec; 119(6186):suppl 1-2. PubMed ID: 20128083
    [No Abstract]   [Full Text] [Related]  

  • 12. The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the road.
    Bathon JM; Cohen SB
    Arthritis Rheum; 2008 Jun; 59(6):757-9. PubMed ID: 18512712
    [No Abstract]   [Full Text] [Related]  

  • 13. Rheumatoid arthritis initial therapy: unanswered questions.
    O'Dell J
    J Rheumatol Suppl; 2005 Jan; 72():14-6. PubMed ID: 15660457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the efficacy of biologic therapy: are there real differences?
    Fleischmann RM
    J Rheumatol Suppl; 2002 Sep; 65():27-32. PubMed ID: 12236619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials in rheumatoid arthritis under attack: are practice based observational studies the answer?
    Felson DT
    J Rheumatol; 1991 Jul; 18(7):951-3. PubMed ID: 1920325
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of conventional drugs and biologic agents for Rheumatoid Arthritis.
    Amoroso A; Gigante A; Gianni C; Amoroso D; Zennaro D; Galluzzo S; Caccavo D
    Eur Rev Med Pharmacol Sci; 2003; 7(5):139-45. PubMed ID: 15214589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.
    Weaver AL; Lautzenheiser RL; Schiff MH; Gibofsky A; Perruquet JL; Luetkemeyer J; Paulus HE; Xia HA; Leff JA;
    Curr Med Res Opin; 2006 Jan; 22(1):185-98. PubMed ID: 16393444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and analysis of a randomized controlled trial testing the effects of clinical decision support on the management of rheumatoid arthritis.
    Fransen J; Twisk JW; Creemers MC; van Riel PL
    Arthritis Rheum; 2004 Feb; 51(1):124-7. PubMed ID: 14872465
    [No Abstract]   [Full Text] [Related]  

  • 19. Preventing joint damage as the best measure of biologic drug therapy.
    Bresnihan B
    J Rheumatol Suppl; 2002 Sep; 65():39-43. PubMed ID: 12236622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint approach.
    Palmer K
    Minn Med; 2009 Sep; 92(9):22-5. PubMed ID: 19877473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.